🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To compare the metabolic and gastrointestinal pharmacod...
Status
Completed
Location
Investigational Site Number 2760001
Start Date
2018-03-12
Trial ID
NCT03462069
Treatments Being Tested
Primary Objective: To demonstrate the superiority of sotagliflozin dose 1 ...
Status
Terminated
Location
Investigational Site Number 1560039
Start Date
2018-11-30
Trial ID
NCT03761134
Treatments Being Tested
Primary Objective: To demonstrate the superiority of Sotagliflozin 400 mil...
Status
Completed
Location
Investigational Site Number 8401049
Start Date
2016-11-11
Trial ID
NCT02926937
Treatments Being Tested
Primary Objective: To demonstrate the superiority of sotagliflozin 400 mil...
Status
Completed
Location
Investigational Site Number 8406028
Start Date
2017-09-15
Trial ID
NCT03285594
Treatments Being Tested
Primary Objective: To compare the effect of sotagliflozin to placebo on th...
Status
Terminated
Location
Investigational Site Number 8400128
Start Date
2018-06-15
Trial ID
NCT03521934
Treatments Being Tested
Primary Objective: To demonstrate the non-inferiority of Sotagliflozin 400...
Status
Completed
Location
Investigational Site Number 8407040
Start Date
2017-12-01
Trial ID
NCT03332771
Treatments Being Tested
The primary objective is to demonstrate the superiority of Sotagliflozin 40...
Status
Terminated
Location
Investigational Site Number 8409009
Start Date
2018-02-19
Trial ID
NCT03386344
Treatments Being Tested
Primary Objective: To assess the absolute bioavailability of sotagliflozin...
Status
Completed
Location
Investigational site number 8260001
Start Date
2019-01-14
Trial ID
NCT03802487
Treatments Being Tested
Primary Objective: To assess the effect of multiple dose mefenamic acid on...
Status
Completed
Location
Investigational site 250001
Start Date
2017-03-14
Trial ID
NCT03070678
Treatments Being Tested
Primary Objectives: * Assess the safety and tolerability of sotagliflozin ...
Status
Terminated
Location
Investigational Site Number 8400005
Start Date
2017-12-04
Trial ID
NCT03292653
Treatments Being Tested